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Large deletion and small insertion mutations in the adenylyl cyclase gene of Saccharomyces cerevisiae were
used to map regions required for activation by RAS protein in vitro. The amino-terminal 605 amino acids were
found to be dispensable for responsiveness to RAS protein. All other deletions in adenylyl cyclase destroyed its
ability to respond to RAS. Small insertion mutations within the leucine-rich repeat region also prevented RAS
responsiveness, while other insertions did not.
In the yeast Saccharomyces cerevisiae there are two
genes, RASI and RAS2, that encode GTP-binding proteins
with both structural and functional homology to the mam-
malian RAS proteins (2, 3, 10, 15). In S. cerevisiae, these
genes are known to play a critical role in determining cellular
responses to nutrient conditions (10, 21). Although the
function of RAS proteins in mammalian cells remains enig-
matic, S. cerevisiae RAS proteins stimulate adenylyl cyclase
(the CYR] gene product), resulting in elevated levels of the
intracellular second messenger cyclic (cAMP). Increased
levels of cAMP are able to derepress the cAMP-dependent
protein kinases. While a RAS deficiency is normally a lethal
event, lethality can be overcome by mutations which in-
crease the constitutive level of cAMP production (4, 9),
decrease cAMP hydrolysis (14), or uncouple the protein
kinases from cAMP regulation (18, 21).
We have been particularly interested in elucidating the
mechanism of RAS-effector interactions in general and ade-
nylyl cyclase stimulation in particular. We have previously
described the purification of yeast adenylyl cyclase and an in
vitro RAS activation assay using yeast RAS2 protein purified
from bacteria (6). We describe here the use of this assay to
analyze mutants of adenylyl cyclase in an effort to determine
the regions required for RAS interaction and stimulation.
MATERIALS AND METHODS
Strains, media, and transformations. Plasmids were prop-
agated in Escherichia coli HB101. Bacterial transformations
were performed by using a standard procedure. The yeast
strain SPK-3T3 (MATat his3 leu2 ura3 trpl ade8 can]
rasi: :H153 ras2:: URA3 pTPK3-TRPI) is a plasmid exchange
derivative of SPK-3 (20). Yeast cultures were grown in either
rich medium (YPD) or synthetic medium (SC) with appro-
priate auxotrophic supplements. Yeast transformations were
performed by using lithium acetate (8). SPK-3T3 cells were
transformed with pYCYR or with mutant constructs which
contain the LEU2 marker. Transformants were grown in
YPD for 2 days in order to allow segregation of the pTPK3-
* Corresponding author.
TRPI plasmid. Segregation analysis yielded cells that were
Leu+ Trp- and that were fully dependent on the extrachro-
mosomal adenylyl cyclase plasmid for viability.
Plasmids and DNA manipulations. The construction of the
plasmid pYCYR has been described previously (7). Deletion
la was produced by digestion ofpYCYR with KpnI and MluI
followed by treatment with mung bean exonuclease to pro-
duce blunt ends and with calf intestinal phosphatase. The
resulting linear DNA was ligated in the presence of a NotI
linker oligonucleotide. The resulting junction was sequenced
(1, 17) to verify that the reading frame was not altered.
Deletion 3a was created by cleaving pEF-CYR1 (6) with
SacI followed by religation at a dilute concentration, result-
ing in the loss of a 3.6-kilobase-pair SacI fragment. The
4.7-kilobase SalI-to-NcoI fragment of this deletion mutant
was then ligated to the 8.8-kilobase SalI-to-NcoI fragment of
pYCYR. All other deletions were constructed by using the
polymerase chain reaction (PCR). This was accomplished by
the utilization of primers that introduce new restriction
endonuclease recognition sites. The restriction site chosen is
positioned to be in frame with, but displaced from, an
identical restriction site in adenylyl cyclase. Deletions were
designed such that they are not accompanied by the addition
of any amino acid residues, except for group III (see below).
Exchange of a wild-type fragment with the PCR product
resulted in the deletion of sequences between the newly
introduced and preexisting restriction sites. Standard PCR
conditions (16) were used, and reactions were stopped after
15 cycles. Each primer had 18 bases of perfect complimen-
tation to adenylyl cyclase sequences. Primers that introduce
new restriction sites included the recognition site sequence
plus either two or four additional nucleotides at their 5' ends.
Group I deletions (exclusive of la and 3a) were made by
introducing a new Sall site and deleting sequences up to the
preexisting SalI site at nucleotide position 656. Similarly,
group II deletions were made by introducing new NcoI sites
upstream of the endogenous NcoI site at nucleotide position
5485. Group III deletions were created by adding back
PCR-generated fragments into the NcoI site of A5. The
resulting large deletions had an additional NcoI site and a
2-amino-acid insertion. In the case of IN6, a full sequence
replacement was made, with the net result of a 3-amino-acid
insertion. Group IV deletions were made by introducing a
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new XhoI site (All and A13) or a Sacl site (A12 and A14).
The endogenous XhoI site and Sacl site are at nucleotide
positions 3858 and 4085, respectively. Insertion mutations
were created by standard oligonucleotide-directed mutagen-
esis (12, 25). The oligonucleotides used contained the insert
sequence GGATCCGGA flanked by 15 nucleotides of per-
fect complementation on each side. The insert sequence
encodes Gly-Ser-Gly and contains a BamHI endonuclease
recognition site. Insertions were confirmed by BamHI diges-
tions.
Adenylyl cyclase purification and analysis. Yeast strains
harboring adenylyl cyclase constructs were grown to late log
phase in 1 liter of YPD. Adenylyl cyclase was purified by
immunoprecipitation from membrane preparations obtained
from 1-liter cultures (6). Catalytic activity determinations
were performed as previously described (6). RAS2 vall9 pro-
teins was used in these assays to stimulate cyclase activity.
We have previously shown that wild-type RAS2 protein will
also work (5). Although the strains used do contain wild-type
adenylyl cyclase, it does not appear to copurify with the
epitope-tagged adenylyl cyclases (unpublished results) and
does not contribute to the measured adenylyl cyclase activ-
ities. Immunoaffinity-purified adenylyl cyclase was sub-
jected to sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis, transferred electrophoretically to nitrocellulose,
and probed with the monoclonal antibody 12CA5 (6) raised
against the peptide epitope. Antibody 12CA5 was used at a
concentration of 3 ,ug/ml. The immunoblot was then devel-
oped with colloidal gold conjugated to goat anti-mouse
immunoglobulin G followed by gold enhancement (Bio-Rad
Laboratories). Molecular weight markers were obtained
from Sigma Chemical Co.
RESULTS
Central to our studies is a yeast adenylyl cyclase expres-
sion system that expresses high levels of the enzyme. The
adenylyl cyclase expression construct, pYCYR, uses the
strong yeast ADH1 promoter to express adenylyl cyclase
fused to a short amino-terminal epitope (Fig. 1). This epitope
is used for immunopurification. The expression plasmid also
contains origins of replication and selectable markers for
growth in yeast and bacteria. Its construction has been
described previously (7). Two other features of adenylyl
cyclase are highlighted in Fig. 1. The carboxy-terminal 418
amino acids, designated as the catalytic domain, are suffi-
cient for Mn2+-dependent cyclase activity but are insuffi-
cient for activation by RAS protein and GTP in the presence
of Mg2" (9). The region from amino acid 733 to 1301, which
we call the leucine-rich repeat region, is composed of 26
copies of an approximately 23-amino-acid repeating unit that
has a high content of aliphatic residues, especially leucine.
The consensus repeat unit is represented in Fig. 1. Mutants
in adenylyl cyclase were generated and tested as described
below.
Plasmids carrying the mutant adenylyl cyclase gene were
transformed into the yeast strain SPK-3T3, which has both
RAS genes disrupted. Since RAS is normally essential for
cell viability, this strain is kept alive with an extrachromo-
somal plasmid, pTPK3-TRPI, that overexpresses TPK3, a
gene encoding a catalytic component of the cAMP-depen-
dent protein kinase (19). All of our adenylyl cyclase con-
structs expressed the catalytic portion of the enzyme, and all
were able to suppress the lethality of a RAS deficiency in this
strain, as determined by plasmid exchange (see Materials
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FIG. 1. Mutational analysis of adenylyl cyclase. A linear repre-
sentation of the adenylyl cyclase protein with the amino-terminal
peptide epitope is shown. The leucine-rich repeat region and the
catalytic domain are also labeled, and the amino acid positions
which demarcate their boundaries are given. The consensus repeat
unit is shown (P, proline; L, leucine; N, asparagine; X, any amino
acid residue; and a, any aliphatic amino acid from the group
methionine, leucine, isoleucine, and valine). The leftmost column
gives the name of each mutant; this is followed by the positions of
the amino acid residues (inclusive) which have been deleted (A) and
the position of the amino acid residue immediately before an
insertion (IN). Deletions are shown graphically with brackets, and
insertions are indicated with arrowheads. Mutants were scored for
RAS responsiveness by using adenylyl cyclase assays as described
in the text. For each deletion mutant and IN6, which were prepared
by PCR, cell extracts were prepared from two independent con-
structs. Testing of independent PCR constructs controlled for the
possibility that additional, unforeseen mutations were introduced in
the PCR and cloning process. A single construct of each of the other
insertion mutants was analyzed. At least two independent adenylyl
cyclase activity measurements were performed on each extract to
determine RAS responsiveness.
and Methods). We were thus able to obtain yeast strains that
have lost the pTPK3-TRPJ plasmid but contain the mutated
CYR] gene. [These strains show no phenotypic abnormali-
ties associated with excessive CYR1 expression (i.e., heat
shock sensitivity).] Adenylyl cyclase was prepared from
these strains by immunoaffinity purification (6), and activity
assays were performed in the presence of Mn2", Mg2+, or
Mg2+ and RAS2 protein. Typical results are shown in Table
1. All mutants had appreciable levels of adenylyl cyclase
activity with Mn2 , indicating that the catalytic function was
not substantially altered and that no frameshift mutations
had been introduced. Some variability was observed in the
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TABLE 1. Activation of mutant adenylyl cyclase
protein by RAS2'
Adenylycyclase activity (pmol of
Strain cAMP generatedt30 min) with: Fold stimulationby RASb
Mn2+ Mg2+ Mg2+ + RAS2
Wild type 165 10.8 204 19.0c
Ala 334 33.5 195 5.8
Al 501 57.8 495 8.6
A2 306 27.7 46.4 1.7d
A3 459 50.8 33.5 0.6
A4 359 36.7 30.9 0.8
a Adenylyl cyclase was immunopurified from yeast membrane preparations
as described previously and assayed in the presence of Mn2+, Mg2+, or Mg2+
plus RAS2Va`lS protein bound to GTP (6). The amount of each extract tested
was chosen to give roughly comparable levels of activity in the presence of
Mn2+ (approximately 10 Rg of protein as crude extract before immobilization
with antibody). Each value presented is the average of two measurements.
b The fold stimulation due to RAS is calculated as (activity measured with
Mg2' plus RAS)/(activity measured with Mg2+).
c The observed RAS-dependent stimulation of wild-type adenylyl cyclase
was usually comparable with that of Ala, Al, and the other RAS-responsive
insertion mutants. It has, however, been measured at lower or higher levels
(as presented here).
d The slight stimulation was not seen when the assay was repeated.
absolute values of adenylyl cyclase activity within these
assays, due in part to differential yields from various ex-
tracts. Mutants were classified as RAS responsive if activity
levels with Mg2" plus RAS were at least fourfold greater
than levels of activity measured with Mg2" alone. Mutants
were classified as unresponsive if activity levels with Mg2"
plus RAS were less than twofold greater than levels of
activity measured with Mg2" alone. All mutants could be
clearly classified. In addition, for RAS-responsive mutants
and wild-type strains, adenylyl cyclase activity in the pres-
ence of Mg2" and RAS was consistently at least 50% of
Mn2" activity. For nonresponsive mutants, this activity was
only 15% or less of the corresponding Mn2" activity.
The first set of deletion mutations we constructed began at
or near the amino terminus of adenylyl cyclase and had
sequences up to and including the leucine-rich repeat region
removed (Fig. 1, group I). Because the epitope-encoding
sequences are not affected by the mutagenesis, all mutants
possesed the same 20 amino acids at their amino termini.
Adenylyl cyclases derived from these mutants were ana-
lyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and were found to have mobilities corresponding to
their predicted sizes (Fig. 2). Two deletions of CYR], Ala
and A3a, were made by restriction endonuclease digestion
and religation. Other deletion mutations in the adenylyl
cyclase-coding sequences were created by using a more
complicated strategy (described in Materials and Methods).
Fragments of the CYR] gene were synthesized in a PCR, and
these fragments were used to construct deletion mutants.
While all of the mutants retained high levels of Mn2+-
dependent activity, only deletions Ala and Al remained
responsive to RAS in the presence of Mg2e. Thus, the
N-terminal 605 amino acids, up to 127 amino acids before the
start of the leucine-rich repeat region, are dispensable.
To determine the importance of the leucine-rich repeat
region and the sequences lying between the repeats and the
catalytic domain, further deletions were created, beginning
with Al, the smallest responsive construct, as the parent
(Fig. 1). The group II deletions all began at the start of the
catalytic domain and removed part or all of the sequences up
to the leucine rich repeat region. Group III deletions are
wt Al A2 L3
200 kDo
92.5 kDo -
69kDa -
46kDa
FIG. 2. Western (immuno-) blot of deleted adenylyl cyclases.
Immunopurified adenylyl cyclases (wild type [wt] and mutant) were
run on a sodium dodecyl sulfate-polyacrylamide gel, transferred to
nitrocellulose, and probed with a monoclonal antibody against the
peptide epitope (see Materials and Methods). Each lane is labeled to
indicate the source of adenylyl cyclase (wild type or deletion
mutant), and the positions of molecular mass markers are indicated
on the left. The blot is a composite of two experiments run
separately. kDa, Kilodaltons.
located in the same area but initiate from the end of the
leucine-rich repeat region and proceed toward the catalytic
domain. None of the deletion mutants in this region retained
RAS responsiveness. Group IV deletions were confined to
the leucine-rich repeat region and were designed so that an
integral number of repeat units was removed in each case.
Deletion endpoints were at equivalent positions within each
repeat. These mutants were also found to be unresponsive to
RAS.
Finally, a series of insertion mutations (group V) was
made within the repeat region and the sequences preceding
the catalytic domain. All insertions were 3 amino acids in
length, and their positions are indicated in Fig. 1. IN1-5, -7,
and -8 were made by standard oligonucleotide-directed mu-
tagenesis (see Materials and Methods) and introduced the
amino acids Gly-Ser-Gly. IN6 was created by using PCR
(see Materials and Methods) and contained the extra amino
acids Ala-Met-Ala. While all of the insertions are located
within areas determined to be required by analysis of the
deletion mutants, only IN2, -3, -4, and -5 were found to
result in a loss of RAS responsiveness. These inserts map
within the leucine-rich repeat region, and each resides at a
nonequivalent position within the repeat unit.
DISCUSSION
Our results demonstrate that the amino-terminal 605
amino acids of adenylyl cyclase are dispensable for RAS
responsiveness. The smallest responsive construct, Al, in-
cludes, in addition to the catalytic domain, the 569-amino-
acid leucine-rich repeat region and a 308-amino-acid region
between the repeat and catalytic domains. Deletion muta-
tions in either of these domains destroyed RAS responsive-
ness. In addition, the 127 amino acids immediately upstream
of the leucine-rich repeat region appear to be required for full
RAS responsiveness. The structural constraints in the leu-
cine-rich repeat appear to be quite exacting. Even small,
VOL. 10, 1990 2541
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3-amino-acid insertions in this region abolished RAS respon-
siveness. In contrast, such mutations in the 308-amino-acid
region are without effect (suggesting that the sequence-
specific requirement for this region might be less important
than its role in maintaining the proper spacing between the
repeat and catalytic regions). These results, and others
described below, point to a critical role for the leucine-rich
repeat in RAS responsiveness. We have previously noted
the growing literature on gene products that contain very
similar leucine-rich repeat motifs as putative protein-binding
domains (7).
Other work supports our assignment of RAS-responsive
regions. Recent cloning and sequencing of adenylyl cyclase
from the yeast Saccharomyces kluyveri (unpublished results)
revealed striking conservation with S. cerevisiae adenylyl
cyclase throughout the region we have defined as the RAS-
responsive structure, but there is nearly complete diver-
gence amino terminal to this region. Further studies are
required to determine whether this pattern of sequence
conservation reflects a functional conservation with regard
to RAS stimulation. The requirement of the leucine-rich
repeat region is also supported by experimentation based
upon an in vivo interference assay. Some adenylyl cyclase
mutants can dominantly interfere with the expression of the
heat shock phenotype resulting from a RAS2'all9 mutation.
Interference can be achieved by expression of little more
than the leucine-rich repeat region, and mutations within this
area abolish interference (7). The requirement for the 308-
amino-acid region between the leucine-rich repeat and the
catalytic domain is supported by observations made by
Marshall et al. (13). They developed a series of attenuated
RAS mutants that were impaired in their ability to stimulate
adenylyl cyclase. These RAS mutants were used to isolate
and characterize a compensator mutation within adenylyl
cyclase that was located at position 1547. Our work is in
conflict with the findings of Uno et al., who claim that little
more than the catalytic domain of adenylyl cyclase is suffi-
cient for RAS responsiveness (22).
In addition to the regions already discussed, important
RAS-responsive elements may lie within the catalytic do-
main. The extent of amino acid residues actually devoted to
the catalysis of cAMP formation may be quite modest as
judged by the level of sequence conservation among adeny-
lyl cyclases of different species (11, 23, 24). The two func-
tions, catalysis and RAS responsiveness, may be intimately
associated and difficult to analyze separately. Some data
implicating catalytic domain sequences in RAS responsive-
ness have recently been reported (23). Finally, we wish to
emphasize that nothing in our studies requires that adenylyl
cyclase interact directly with RAS. The adenylyl cyclase
obtained from yeast purifies as a complex with at least one
other protein component, a 70-kilodalton subunit. The role
of this protein is currently under study. The loss of RAS
responsiveness in a mutant adenylyl cyclase might reflect an
altered interaction with other elements of the adenylyl
cyclase complex.
ACKNOWLEDGMENTS
We thank P. Bird for preparation of the manuscript.
This work was supported by Public Health Service grants from
the National Institutes of Health (NIH), by grants from the Ameri-
can Cancer Society, and by the Pfizer Biomedical Research Award.
J.F. and R.B. are supported by NIH fellowships. M.W. is an
American Cancer Society Research Professor.
LITERATURE CITED
1. Biggin, M. D., T. J. Gibson, and G. F. Hong. 1983. Buffer
gradient gels and 35S label as an aid to rapid DNA sequence
determination. Proc. Natl. Acad. Sci. USA 80:3963-3965.
2. DeFeo-Jones, D., E. M. Scolnick, R. Kolier, and R. Dhar. 1983.
ras-related gene sequences identified and isolated from Saccha-
romyces cerevisiae. Nature (London) 306:707-709.
3. DeFeo-Jones, D., K. Tatchell, L. C. Robinson, I. Sigal, W. Vass,
D. R. Lowy, and E. M. Scolnick. 1985. Mammalian and yeast ras
gene products: biological function in their heterologous sys-
tems. Science 228:179-184.
4. De Vendittis, E., A. Vitelli, R. Zahn, and 0. Fasano. 1986.
Suppression of defective RAS] and RAS2 functions in yeast by
an adenylate cyclase activated by a single amino acid change.
EMBO J. 5:3657-3663.
5. Field, J., D. Broek, T. Kataoka, and M. Wigler. 1987. Guanine
nucleotide activation of, and competition between, RAS pro-
teins from Saccharomyces cerevisiae. Mol. Cell. Biol. 7:2128-
2133.
6. Field, J., J. Nikawa, D. Broek, B. MacDonald, R. Rodgers, I. A.
Wilson, R. A. Lerner, and M. Wigler. 1988. Purification of a
RAS-responsive adenylyl cyclase complex from Saccharomy-
ces cerevisiae by use of an epitope addition method. Mol. Cell.
Biol. 8:2159-2165.
7. Field, J., H.-P. Xu, T. Michaeli, M. Sass, M. Wigler, and J.
Colicelli. 1990. The leucine rich repeat region of the S. cerevi-
siae adenylyl cyclase gene interferes with Ras function. Science
247:464-467.
8. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transfor-
mation of intact yeast cells treated with alkali cations. J.
Bacteriol. 153:163-168.
9. Kataoka, T., D. Broek, and M. Wigler. 1985. DNA sequence and
characterization of the S. cerevisiae gene encoding adenylate
cyclase. Cell 43:493-505.
10. Kataoka, T., S. Powers, S. Cameron, 0. Fasano, M. Goldfarb, J.
Broach, and M. Wigler. 1985. Functional homology of mamma-
lian and yeast RAS genes. Cell 40:19-26.
11. Krupinski, J., F. Coussen, H. A. Bakalyar, W.-J. Tang, G.
Feinstein, K. Orth, C. Slaughter, R. R. Reed, and A. G. Gilman.
1989. Adenylyl cyclase amino acid sequence: possible channel-
or transporter-like structure. Science 244:1558-244.
12. Kunkel, T. 1985. Rapid and effective site-specific mutagenesis
without phenotypic selection. Proc. Natl. Acad. Sci. USA
82:488-492.
13. Marshall, M. S., J. B. Gibbs, E. M. Scolnick, and I. S. Sigal.
1988. An adenylate cyclase from Saccharomyces cerevisiae that
is stimulated by RAS proteins with effector mutations. Mol.
Cell. Biol. 8:52-61.
14. Nikawa, J., S. Cameron, T. Toda, K. M. Ferguson, and M.
Wigler. 1987. Rigorous feedback control of cAMP levels in
Saccharomyces cerevisiae. Genes Dev. 1:931-937.
15. Powers, S., T. Kataoka, 0. Fasano, M. Goldfarb, J. Strathern, J.
Broach, and M. Wigler. 1984. Genes in S. cerevisiae encoding
proteins with domains homologous to the mammalian ras pro-
teins. Cell 36:607-612.
16. Saiki, R., D. Gelfand, S. Stoffe, S. Scharf, R. Higushi, G. Horn,
K. Mullis, and H. Erlich. 1988. Primer-directed enzymatic
amplification of DNA with a thermostable DNA polymerase.
Science 239:489-491.
17. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequenc-
ing with chain-terminating inhibitors. Proc. Natl. Acad. Sci.
USA 74:5463-5467.
18. Toda, T., S. Cameron, P. Sass, M. Zoller, J. D. Scott, B.
McMullen, M. Hurwitz, E. G. Krebs, and M. Wigler. 1987.
Cloning and characterization of BCYI, a locus encoding a
regulatory subunit of the cAMP-dependent protein kinase in
yeast. Mol. Cell. Biol. 7:1371-1377.
19. Toda, T., S. Cameron, P. Sass, and M. Wigler. 1987. Three
different genes in the yeast Saccharomyces cerevisiae encode
the catalytic subunits of the cAMP dependent protein kinase.
Cell 50:277-287.
20. Toda, T., S. Cameron, P. Sass, and M. Wigler. 1988. SCH9, a
MOL. CELL. BIOL.
 o
n
 April 19, 2012 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
S. CEREVISIAE ADENYLYL CYCLASE RAS-RESPONSIVE DOMAINS
gene of S. cerevisiae that encodes a protein distinct from, but
functionally and structurally related to, cAMP dependent pro-
tein kinase catalytic subunits. Genes Dev. 2:517-527.
21. Toda, T., I. Uno, T. Ishikawa, S. Powers, T. Kataoka, D. Broek,
S. Cameron, J. Broach, K. Matsumoto, and M. Wigler. 1985. In
yeast, RAS proteins are controlling elements of adenylate
cyclase. Cell 40:27-36.
22. Uno, I., U. H. Mitsuzawa, K. Tanaka, T. Oshima, and T.
Ishikawa. 1987. Identification of the domain of Saccharomyces
cerevisiae adenylate cyclase associated with the regulatory
function of RAS products. Mol. Gen. Genet. 210:187-194.
23. Yamawaki-Kataoka, Y., T. Tamaoki, H.-R. Choe, H. Tanaka,
and T. Kataoka. 1989. Adenylate cyclase in yeast: a compar-
ison of the genes from Schizosaccharomyces pombe and
Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 86:
5693-5697.
24. Young, D., M. Riggs, J. Field, A. Vojtek, D. Broek, and M.
WigIer. 1989. The adenylyl cyclase gene from Schizosaccharo-
myces pombe. Proc. Natl. Acad. Sci. USA 86:7989-7993.
25. ZolHer, M., and M. Smith. 1984. Oligonucleotide directed muta-
genesis: a simple method using two oligonucleotide primers and
a single stranded DNA template. DNA 3:479-488.
VOL. 10, 1990 2543
 o
n
 April 19, 2012 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
